Hui‐Chuan Sun

Sinopec (China) — China

Medicine · Health Sciences

74h-index21.6kcitations527works3.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatocellular Carcinoma Treatment and Prognosis(187), Cholangiocarcinoma and Gallbladder Cancer Studies(72), Cancer, Hypoxia, and Metabolism(68), Liver Disease Diagnosis and Treatment(54), Ferroptosis and cancer prognosis(50)

Publications525 total

Glecirasib plus sitneprotafib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 1/2a trial
The Lancet Respiratory Medicine·2025· 1 cited
Adjuvant camrelizumab combined with capecitabine in patients with intrahepatic cholangiocarcinoma after surgical resection in China (ACC): a single-arm, single-centre, open-label, phase 2 trial
˜The œLancet. Gastroenterology & hepatology·2025
Zanidatamab in HER2-Positive Metastatic Biliary Tract Cancer
JAMA Oncology·2025Open Access
Diagnostic and therapeutic potential of resolvin D1 in Guillain–Barré syndrome
Journal of Advanced Research·2025Open Access
Development and Validation of a Preoperative Glycolipid Metabolism-Based Nomogram for Predicting Postoperative Recurrence in Primary Glioma: A Retrospective Cohort Study
2025Open Access
Association of serum hepatitis B surface antigen with hepatitis B virus DNA and hepatic function in patients with chronic hepatitis B
World Journal of Gastrointestinal Surgery·2025· 1 citedOpen Access
Anti-PD1 antibody toripalimab combined with lenvatinib, or GEMOX chemotherapy combined with lenvatinib as first-line therapy in patients with advanced intrahepatic cholangiocarcinoma: a randomized, open, two-cohort Phase 2 Study
BMC Medicine·2025· 1 citedOpen Access
Galectin-4 drives anti-PD-L1/BVZ resistance by regulating metabolic adaptation and tumour-associated neutrophils in hepatocellular carcinoma
Gut·2025· 3 cited
Exploring the diagnostic value of dynamic contrast-enhanced and diffusion tensor imaging of intratumoural and peritumoural high-grade gliomas for distinguishing treatment response from tumour progression
Clinical Radiology·2025
1469MO Liver resection versus continued atezolizumab plus bevacizumab (atezo/bev) in locally advanced hepatocellular carcinoma (HCC) after atezo/bev treatment (TALENTop): A multicenter, open-label, randomized phase III trial
Annals of Oncology·2025· 1 cited
A novel triple-localization technique for precise margin determination in endoscopic breast-conserving surgery
Asian Journal of Surgery·2025Open Access
Structural characterization of five functional states of metabotropic glutamate receptor 8
Molecular Cell·2025· 2 citedOpen Access
Conversion therapy of tislelizumab plus lenvatinib and GEMOX in unresectable locally advanced biliary tract cancer (ZSAB-TransGOLP): a multicentre, prospective, phase 2 study
The Lancet Oncology·2025· 5 cited
First-line tislelizumab and ociperlimab combined with gemcitabine and cisplatin in advanced biliary tract cancer (ZSAB-TOP): a multicenter, single-arm, phase 2 study
Signal Transduction and Targeted Therapy·2025· 2 citedOpen Access
Ovis2.5 Technical Report
arXiv (Cornell University)·2025Open Access
Multi-specialty Physician Preferences and Perceptions in Treatment and Management of Polycystic Ovary Syndrome in China: Survey and Discrete Choice Experiment
Advances in Therapy·2025Open Access
Optimizing a complex intervention for community-dwelling frail older adults: A factorial randomized trial within the multiphase optimization strategy framework
International Journal of Nursing Studies·2025
Electromagnetic scattering field of transmission lines in half-space background
Discover Applied Sciences·2025Open Access
Phosphatidylserine Ameliorates High‐Fat Diet‐Induced Obesity Through Modulating the Bile Acid Metabolism and Gut Microbiota
Journal of Food Science·2025
Effect of varying doses of dexmedetomidine added to dexamethasone-enhanced TAPB for post-cesarean pain management
Frontiers in Medicine·2025Open Access
page 1 of 27Next →

Frequent Co-authors

Jia Fan(28), Zhao–You Tang(19), Xiao‐Dong Zhu(15), Jian Zhou(15), Lun–Xiu Qin(13), Xin‐Rong Yang(9), Yuan Ji(9), Ying‐Hong Shi(8), Jian Zhou(8), Lu Wang(7), Shuang‐Jian Qiu(6), Guo‐Ming Shi(6), Wei‐Zhong Wu(6), Minshan Chen(5), Xiaowu Huang(5), Sheng‐Long Ye(5), Ti Zhang(5), Feng Shen(5), Zhao–You Tang(5), Zong‐Tao Chai(5)